The effectiveness of dexamethasone as a combination therapy for COVID-19
Coronavirus disease 2019 (COVID-19) was reported as a global pandemic in March 2020 after invading many countries and leaving behind tens of thousands of infected patients in a brief time span. Approval of a few vaccines has been obtained and their efficacy of varying degrees established. Still, the...
Saved in:
Main Author: | Namazi Nader |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-09-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2022-0030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
by: Atri Das, et al.
Published: (2023-10-01) -
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
by: S.J.W. Kang, et al.
Published: (2024-10-01) -
Comparative Analysis of COVID‐19 Severity and Mortality Among Vaccinated and Unvaccinated Individuals During the Delta Variant Surge in a Tertiary Care Center: A Cohort Study
by: Fatemeh Hasani, et al.
Published: (2025-01-01) -
A systematic review and meta-analysis of the association between galectin-3 levels and clinical outcomes in COVID-19 patients
by: Kacper DZIEDZIC, et al.
Published: (2023-12-01) -
Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
by: Vaidyanathan Gowri, et al.
Published: (2024-01-01)